| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 四川和邦生物科技股份有限公司主营业务为化工制造及盐矿、磷矿的开发.报告期内,公司主要产品包括纯碱和氯化铵,其中纯碱是基础化工原料,主要用于玻璃制造和洗涤剂合成,此外还用于冶金、造纸、印染、食品制造等;氯化铵是一种基础氮肥,也是目前农业部积极推广的复合肥的主要原料.公司成立以来一直致力于一体化经营,通过资源、能源的就地转化,实现循环经济,促进企业的可持续发展.2010年,公司新建的60万吨/年联碱装置投产,并将原有控股子公司重庆碱胺和乐天化的落后产能淘汰;同时,公司收购了同一控制下的盐矿采矿权及采盐相关经营性资产,实现了产业链向上游的延伸.公司现有80万吨/年纯碱和氯化铵产能,纯碱产能位居国内第九名,氯化铵产能位居国内第三名,拥有两座盐矿的采矿权,采盐规模210万吨/年,公司还拥有一座磷矿采矿权,设计开采规模100万吨/年。 | ||||||||||||||||||||||||
| Main Business | 化工制造、农药制造、玻璃制造以及盐矿、磷矿的开发。 | ||||||||||||||||||||||||
| Legal Representative | 曾小平 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 蒋思颖 | ||||||||||||||||||||||||
| Solicitors | 北京国枫律师事务所 | ||||||||||||||||||||||||
| Auditors | 四川华信（集团）会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 028-62050230 | ||||||||||||||||||||||||
| Fax No | 028-62050290 | ||||||||||||||||||||||||
| Website | www.hebang.cn | ||||||||||||||||||||||||
| jsy@hebang.cn；yq@hebang.cn | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 31/07/2012 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.147 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 2.217 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 18.811B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |